1.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 and over
Sponsor:
Protocol IDs: PVSG-10
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-875001, MAYO-875001, NCCTG-87-50-01
|
|
3.
|
Phase: Phase III
Type: Prevention
Status: Closed
Age: over 30 to under 75
Sponsor: NCI
Protocol IDs: CLB-9270, E-C9270, NCCTG-949251, NCI-P93-0048, NCT00002527
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: BARTS-DAVDAS, EU-20610, ISRCTN13255144, NCT00316927
|
|
5.
|
Phase: Phase III
Type: Prevention
Status: Closed
Age: 40 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: COLO CP-01-US, NCT00486512
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000404161, ECOG-E4A03, NCT00098475
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8802D, NCI-88-C-84D, NCI-T88-0103N, T88-0103
|
|
8.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-00-C-0128, MB-401, NCI-T99-0066, T99-0066, NCT00020189
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MAYO-851901, NCI-T85-0264D, T85-0264
|
|
10.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: RPMI-DS-8816, NCI-V88-0553
|
|
11.
|
Phase: Phase II
Type: Prevention
Status: Closed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: MDA-ID-01454, NCT00062023
|
|
12.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-0427, NCT00263211
|
|
13.
|
Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CCUM-9215, NCI-P93-0040
|
|
14.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: CDR0000540545, NU-NWU04-2-03, NCT00468910
|
|
15.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7803
|
|
16.
|
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 21 to 80
Sponsor: NCI
Protocol IDs: DMS-CPHS-10293, NCI-P95-0063
|
|
17.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor:
Protocol IDs: PVSG-5
|
|
18.
|
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 75 and under
Sponsor: Other
Protocol IDs: QMC-UKCAP, EU-20045, NCT00033319
|
|
19.
|
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 45 and over
Sponsor: NCI, NHLBI
Protocol IDs: BWH-WHS, BWH-1999-P-001304, BWH-2004-P-001661, BWH-88-02744, NCI-P92-0024, NCT00000479
|
|
20.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 55 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000544639, FHCRC-PHS-1908.00, FHCRC-1908, NCT00470561
|
